This inventor holds 2 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2021-2023.
Company Filing History:
Years Active: 2021-2023
Title: Taiki Hanari: Innovator in Benzazepine Derivatives
Introduction
Taiki Hanari is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his work on benzazepine derivatives. With a total of 2 patents, Hanari's innovations are paving the way for new medical applications.
Latest Patents
Hanari's latest patents focus on novel benzazepine compounds that exhibit vasopressin V and V antagonisms. These compounds, described in his patents, are characterized by a specific formula that includes various substituents and hydrocarbon rings. The medical uses of these compounds are expected to have a substantial impact on therapeutic practices.
Career Highlights
Taiki Hanari is currently employed at Otsuka Pharmaceutical Company, Limited, where he continues to develop innovative solutions in the pharmaceutical industry. His work is instrumental in advancing the understanding and application of benzazepine derivatives in medicine.
Collaborations
Hanari collaborates with notable colleagues such as Masatoshi Takuwa and Satoshi Matsuda. Their combined expertise contributes to the success of their projects and the advancement of their research.
Conclusion
Taiki Hanari's contributions to the field of medicinal chemistry through his patents on benzazepine derivatives highlight his role as an influential inventor. His work at Otsuka Pharmaceutical Company, Limited, along with his collaborations, underscores the importance of innovation in healthcare.